Dabigatran etexilate for nonvalvular atrial fibrillation in real practice and promises for its use to prevent stroke

The capabilities of antithrombotic therapy to prevent thromboembolic events in nonvalvular atrial fibrillation (AF) are substantially extended after designing and clinically introducing new oral anticoagulants, one of which is dabigatran. A wealth of world clinical experience with dabigatran has con...

Full description

Bibliographic Details
Main Author: A.V. Fonyakin
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2014-06-01
Series:Nevrologiâ, Nejropsihiatriâ, Psihosomatika
Subjects:
Online Access:https://nnp.ima-press.net/nnp/article/view/394